Plasmacytoid dendritic cell neoplasm treated successfully with rituximab.
Kedward
A L
AL
McGalie
C
C
Venkatraman
L
L
Hamilton
J
J
El-Agnaf
M
M
McKenna
K
K
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003713:Dendritic Cells / Q000473:pathology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015649:Pentostatin / Q000008:administration & dosage; D000069283:Rituximab; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015649:Pentostatin; D000069283:Rituximab; D003520:Cyclophosphamide